How it works
Novel Cellpoint
CAR-T treatments
Clinical centers of excellence are selected, having experienced clinical teams and a local cell processing facility. The centers are provided with Lonza’s Cocoon™ platform, a fully closed and automated manufacturing device, a kit comprising CAR-T reagents, and full training and support. Clinicians are thereby enabled to schedule and perform CAR-T treatments within a week, without any logistics. The secure online xCellit platform is used to facilitate scheduling and monitoring of the CAR-T treatment workflow.
CellPoint CAR-T are investigational and have not been authorized yet.
FAQ
Frequently Asked Questions
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.